Open AccessSacituzumab govitecan — a new therapy for patients with triple-negative breast cancer
Author(s) -
Katarzyna Pogoda,
Agnieszka Jagiełło-Gruszfeld,
Aniwińska,
Zbigniew Nowecki
Publication year - 2022
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2022.0003
Subject(s) - medicine , triple negative breast cancer , irinotecan , oncology , breast cancer , chemotherapy , antibody drug conjugate , cancer , monoclonal antibody , immunology , antibody , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom